SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
U.S. Sen. Bernie Sanders (I-Vt.) presides over a Senate Health, Education, Labor, and Pensions Committee hearing on November 14, 2023 in Washington, D.C.
"The American people have a right to know why it is that they pay, by far, the highest prices in the world for prescription drugs," said the Vermont senator.
U.S. Sen. Bernie Sanders and every Democratic member of the committee he chairs sent letters on Tuesday inviting the CEOs of three major pharmaceutical companies to testify at an upcoming hearing on the nation's prescription drug costs, which are so high that millions of Americans are forced to ration their medications to save money.
"The American people have a right to know why it is that they pay, by far, the highest prices in the world for prescription drugs while the pharmaceutical industry in the U.S. makes hundreds of billions in profits and pays their CEOs tens of millions of dollars in compensation," Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, said in a statement.
In letters to the top executives of Johnson & Johnson, Merck, and Bristol Myers Squibb, Sanders and his Democratic colleagues asked, "How does it happen that one out of four Americans cannot afford to take the medicine their doctors prescribe while prescription drug companies make billions in profits and pay their executives exorbitant compensation packages?"
"How does it happen," the letters continue, "that the median price of new prescription drugs in the United States was over $220,000 last year, while the pharmaceutical industry spent billions on stock buybacks and dividends?"
Johnson & Johnson, Merck, and Bristol Myers Squibb are some of the U.S. pharmaceutical industry's biggest offenders when it comes to charging Americans exorbitant prices for medications that can be purchased at a fraction of the cost in other countries.
In a statement, Sanders' office pointed to Johnson & Johnson and AbbVie's Imbruvica, a blood cancer drug that carries a list price of roughly $204,000 for an annual supply in the U.S. The drug sells for $46,000 annually in the United Kingdom and $43,000 in Germany.
Imbruvica is one of the 10 drugs that the Biden administration selected for an initial round of price negotiations with Medicare, which was empowered to directly negotiate prescription medicine costs with pharmaceutical companies under the Inflation Reduction Act.
The three companies run by the invited executives have all sued the Biden administration over the Medicare price negotiations. In September, a federal judge in Ohio rejected an effort by the U.S. Chamber of Commerce to halt the negotiations.
Sanders said Tuesday that he looks forward to "hearing from the CEOs of large pharmaceutical companies directly on this critical issue."
"I also look forward to working with my colleagues in the Senate to lower the outrageously high price of prescription drugs," the senator added. "A lifesaving drug is not effective if the patient who needs that drug cannot afford it."
The hearing—titled "Why Does the United States Pay, By Far, the Highest Prices in the World for Prescription Drugs?"—is set to take place on January 25, 2024.
Dear Common Dreams reader, The U.S. is on a fast track to authoritarianism like nothing I've ever seen. Meanwhile, corporate news outlets are utterly capitulating to Trump, twisting their coverage to avoid drawing his ire while lining up to stuff cash in his pockets. That's why I believe that Common Dreams is doing the best and most consequential reporting that we've ever done. Our small but mighty team is a progressive reporting powerhouse, covering the news every day that the corporate media never will. Our mission has always been simple: To inform. To inspire. And to ignite change for the common good. Now here's the key piece that I want all our readers to understand: None of this would be possible without your financial support. That's not just some fundraising cliche. It's the absolute and literal truth. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. Will you donate now to help power the nonprofit, independent reporting of Common Dreams? Thank you for being a vital member of our community. Together, we can keep independent journalism alive when it’s needed most. - Craig Brown, Co-founder |
U.S. Sen. Bernie Sanders and every Democratic member of the committee he chairs sent letters on Tuesday inviting the CEOs of three major pharmaceutical companies to testify at an upcoming hearing on the nation's prescription drug costs, which are so high that millions of Americans are forced to ration their medications to save money.
"The American people have a right to know why it is that they pay, by far, the highest prices in the world for prescription drugs while the pharmaceutical industry in the U.S. makes hundreds of billions in profits and pays their CEOs tens of millions of dollars in compensation," Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, said in a statement.
In letters to the top executives of Johnson & Johnson, Merck, and Bristol Myers Squibb, Sanders and his Democratic colleagues asked, "How does it happen that one out of four Americans cannot afford to take the medicine their doctors prescribe while prescription drug companies make billions in profits and pay their executives exorbitant compensation packages?"
"How does it happen," the letters continue, "that the median price of new prescription drugs in the United States was over $220,000 last year, while the pharmaceutical industry spent billions on stock buybacks and dividends?"
Johnson & Johnson, Merck, and Bristol Myers Squibb are some of the U.S. pharmaceutical industry's biggest offenders when it comes to charging Americans exorbitant prices for medications that can be purchased at a fraction of the cost in other countries.
In a statement, Sanders' office pointed to Johnson & Johnson and AbbVie's Imbruvica, a blood cancer drug that carries a list price of roughly $204,000 for an annual supply in the U.S. The drug sells for $46,000 annually in the United Kingdom and $43,000 in Germany.
Imbruvica is one of the 10 drugs that the Biden administration selected for an initial round of price negotiations with Medicare, which was empowered to directly negotiate prescription medicine costs with pharmaceutical companies under the Inflation Reduction Act.
The three companies run by the invited executives have all sued the Biden administration over the Medicare price negotiations. In September, a federal judge in Ohio rejected an effort by the U.S. Chamber of Commerce to halt the negotiations.
Sanders said Tuesday that he looks forward to "hearing from the CEOs of large pharmaceutical companies directly on this critical issue."
"I also look forward to working with my colleagues in the Senate to lower the outrageously high price of prescription drugs," the senator added. "A lifesaving drug is not effective if the patient who needs that drug cannot afford it."
The hearing—titled "Why Does the United States Pay, By Far, the Highest Prices in the World for Prescription Drugs?"—is set to take place on January 25, 2024.
U.S. Sen. Bernie Sanders and every Democratic member of the committee he chairs sent letters on Tuesday inviting the CEOs of three major pharmaceutical companies to testify at an upcoming hearing on the nation's prescription drug costs, which are so high that millions of Americans are forced to ration their medications to save money.
"The American people have a right to know why it is that they pay, by far, the highest prices in the world for prescription drugs while the pharmaceutical industry in the U.S. makes hundreds of billions in profits and pays their CEOs tens of millions of dollars in compensation," Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, said in a statement.
In letters to the top executives of Johnson & Johnson, Merck, and Bristol Myers Squibb, Sanders and his Democratic colleagues asked, "How does it happen that one out of four Americans cannot afford to take the medicine their doctors prescribe while prescription drug companies make billions in profits and pay their executives exorbitant compensation packages?"
"How does it happen," the letters continue, "that the median price of new prescription drugs in the United States was over $220,000 last year, while the pharmaceutical industry spent billions on stock buybacks and dividends?"
Johnson & Johnson, Merck, and Bristol Myers Squibb are some of the U.S. pharmaceutical industry's biggest offenders when it comes to charging Americans exorbitant prices for medications that can be purchased at a fraction of the cost in other countries.
In a statement, Sanders' office pointed to Johnson & Johnson and AbbVie's Imbruvica, a blood cancer drug that carries a list price of roughly $204,000 for an annual supply in the U.S. The drug sells for $46,000 annually in the United Kingdom and $43,000 in Germany.
Imbruvica is one of the 10 drugs that the Biden administration selected for an initial round of price negotiations with Medicare, which was empowered to directly negotiate prescription medicine costs with pharmaceutical companies under the Inflation Reduction Act.
The three companies run by the invited executives have all sued the Biden administration over the Medicare price negotiations. In September, a federal judge in Ohio rejected an effort by the U.S. Chamber of Commerce to halt the negotiations.
Sanders said Tuesday that he looks forward to "hearing from the CEOs of large pharmaceutical companies directly on this critical issue."
"I also look forward to working with my colleagues in the Senate to lower the outrageously high price of prescription drugs," the senator added. "A lifesaving drug is not effective if the patient who needs that drug cannot afford it."
The hearing—titled "Why Does the United States Pay, By Far, the Highest Prices in the World for Prescription Drugs?"—is set to take place on January 25, 2024.